5-HT4 antagonists (Lilly/Shire)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT4 antagonists (Lilly/Shire)
Drug Alias Name5-HT4 antagonists (Lilly/Roberts)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor antagonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShireEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A